Histogen Stock Analysis

Histogen Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Histogen recorded a loss per share of 2.81. The entity last dividend was issued on the 27th of May 2020. The firm had 1:20 split on the 3rd of June 2022. Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To learn more about Histogen call Susan Knudson at 858 526 3100 or check out https://www.histogen.com.

Histogen Investment Alerts

Histogen Upcoming and Recent Events

Histogen Largest EPS Surprises

View All Earnings Estimates

Histogen Stock Institutional Investors

Note, although Histogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Histogen Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 85.44 K.

Histogen Profitablity

Management Efficiency

Histogen has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.67. In addition to that, Return On Capital Employed is likely to drop to -0.72. At this time, Histogen's Total Assets are very stable compared to the past year. As of the 28th of November 2024, Non Current Assets Total is likely to grow to about 6.8 M, while Total Current Assets are likely to drop about 11.5 M.

Technical Drivers

As of the 28th of November, Histogen retains the Market Risk Adjusted Performance of 1.18, risk adjusted performance of (0.07), and Standard Deviation of 13.17. Histogen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Histogen Price Movement Analysis

Histogen Insider Trading Activities

Histogen Outstanding Bonds

Histogen Predictive Daily Indicators

Histogen Forecast Models

Histogen's time-series forecasting models are one of many Histogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Histogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Histogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Histogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Histogen. By using and applying Histogen Stock analysis, traders can create a robust methodology for identifying Histogen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Histogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Histogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Histogen stock analysis indicators help investors evaluate how Histogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Histogen shares will generate the highest return on investment. By understating and applying Histogen stock analysis, traders can identify Histogen position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.